|
2025
|
Invention
|
Compositions and methods for diagnosis and treatment of neurodegenerative diseases.
Compositions... |
|
|
Invention
|
Fatty acid analogs and their use in the treatment of cognitive impairment, behavioral conditions,... |
|
2024
|
Invention
|
Compositions and methods for diagnosis and treatment of conditions related to the quality of agin... |
|
|
Invention
|
Fatty acid analogs and their use in the treatment of conditions related to metabolic syndrome.
C... |
|
2023
|
Invention
|
Compositions and methods for diagnosis and treatment of conditions related to aging.
Composition... |
|
|
Invention
|
Compositions and methods for mood enhancement.
Compositions including odd chain saturated fatty ... |
|
|
Invention
|
Compositions and methods for treatment of obesity.
Compositions including odd chain saturated fa... |
|
2022
|
Invention
|
Pentadecanoylcarnitine for treatment of conditions related to the quality of aging and longevity.... |
|
2021
|
Invention
|
Compositions and methods for treatment of obesity. Compositions including odd chain saturated fat... |
|
|
Invention
|
Compositions and methods for mood enhancement. Compositions including odd chain saturated fatty a... |
|
|
Invention
|
Compositions and methods for diagnosis and treatment of neurodegenerative diseases. Compositions ... |
|
2020
|
Invention
|
Fatty acid analogs and their use in the treatment of conditions related to metabolic syndrome. Co... |
|
2019
|
G/S
|
Pharmaceutical products development; Pharmaceutical research and development; Development of phar... |
|
|
Invention
|
Compositions and methods for diagnosis and treatment of conditions related to aging. Compositions... |
